Halozyme Therapeutics, Inc. (HALO): aksiya narxi va yangiliklar

Belgilar Belgilar	Narxi	Oʻzgartirishlar	Dinamika (%)	Trend	Avvalgi yopilish narxi	Ochish	Yuqori	Past	Hajmi	Bozor kapitali
SIXB Materials SIXB Materials	SIXB +0,99%	1 093,81	+10,77	+0,99%	—	1 083,04	1 082,63	1 099,01	1 080,59	—	—
SIXC Communications SIXC Communications	SIXC +1,06%	608,77	+6,39	+1,06%	—	602,38	602,38	609,75	599,75	—	—
SIXE Energy SIXE Energy	SIXE +0,96%	1 254,81	+11,98	+0,96%	—	1 242,83	1 229,31	1 258,88	1 220,51	—	—
SIXI Industrials SIXI Industrials	SIXI +2,76%	1 761,11	+47,29	+2,76%	—	1 713,82	1 715,47	1 763,11	1 715,47	—	—
SIXM Financials SIXM Financials	SIXM +0,40%	642,58	+2,59	+0,40%	—	639,99	636,98	644,04	631,81	—	—
SIXR Staples SIXR Staples	SIXR +1,63%	851,13	+13,67	+1,63%	—	837,46	840,30	852,55	840,30	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +1,76%	217,98	+3,76	+1,76%	—	214,22	214,22	218,25	214,05	—	—
SIXT Technology SIXT Technology	SIXT +0,23%	3 211,83	+7,45	+0,23%	—	3 204,38	3 215,04	3 217,44	3 159,90	—	—
SIXU Utilities SIXU Utilities	SIXU +2,55%	948,98	+23,60	+2,55%	—	925,38	927,91	949,76	927,91	—	—
SIXV Health care SIXV Health care	SIXV +2,20%	1 474,52	+31,81	+2,20%	—	1 442,71	1 443,01	1 477,90	1 443,01	—	—
SIXY Discretionary SIXY Discretionary	SIXY +1,30%	2 392,12	+30,78	+1,30%	—	2 361,34	2 391,00	2 399,18	2 354,52	—	—

HALO:NASDAQ

Halozyme Therapeutics, Inc.

63,66 US$

+0,95%

(+0,60) 1K

64,29 US$

+1,00% (+0,63)

Yopilgandan keyin

Savdolar yopilgan: 30-apr, 16:00:00 (GMT-4) · USD

Barcha belgilar

YBB

MAKS

	Belgi	Narxi	Oʻzgartirishlar	Dinamika (%)

HALO tikeri uchun statistika yaratilmoqda...

Ochish

63,21 US$

Yuqori

64,34 US$

Past

63,10 US$

Bozor kapitali

7,54 mlrd

Oʻrtacha hajm

1,46 mln

Hajmi

0,00

P/E koeffitsiyenti

24,89

52 haftalik eng yuqori

82,22 US$

52 haftalik eng past

47,50 US$

Aksiya boʻyicha daromad

2,56 US$

Beta

1,03

Muomaladagi aksiyalar

118,47 mln

Xodimlar soni

423

Aloqador aksiyalar

VRTX

Vertex Pharmaceuticals Inc

Regeneron Pharmaceuticals

707,06 US$

+3,02%

Yangiliklar

Internetdagi manbalardan

Yahoo Finance

8 soat oldin

Halozyme to Report First Quarter 2026 Financial and Operating Results

citybiz

13 soat oldin

Halozyme Names Darren Snellgrove Chief Financial Officer to Lead Financial Strategy and Capital Allocation

Stock Titan

14 soat oldin

Vanguard holds 6.17M Halozyme shares (5.21%) (NASDAQ: HALO)

TipRanks

15 soat oldin

Halozyme Appoints New Chief Financial Officer to Drive Growth

Profil

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia

Halozyme Therapeutics, Inc. haqida

CEOHelen I. Torley

Xodimlar soni423

Asos solingan1998

Bosh ofislarSan Diego, Kaliforniya, Amerika Qo‘shma Shtatlari

Sektor-

Veb-saythalozyme.com

Barcha qiymatlar – USD	mar, 2025	iyn, 2025	sen, 2025	dek, 2025
Daromad	264,86 mln	325,72 mln	354,26 mln	451,77 mln
Sotilgan mahsulotning tannarxi	63,20 mln	46,36 mln	72,49 mln	110,67 mln
Daromad narxi	63,20 mln	46,36 mln	72,49 mln	110,67 mln
Tadqiqot va ishlanmalarga xarajatlar	-	17,54 mln	-	-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar	-	-	-	-
Tijoriy, umumiy va maʼmuriy xarajatlar	42,36 mln	41,61 mln	46,09 mln	63,33 mln
Operatsion xarajatlar	60,12 mln	76,92 mln	63,85 mln	86,70 mln
Jami operatsion xarajatlar	123,33 mln	123,28 mln	136,34 mln	197,37 mln
Operatsion daromad	141,54 mln	202,44 mln	217,92 mln	254,40 mln
Boshqa nooperatsion daromad	-	6,89 mln	-	-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar	143,83 mln	204,94 mln	218,96 mln	-100,85 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno	142,12 mln	204,94 mln	218,96 mln	251,58 mln
Daromad soligʻi boʻyicha xarajat	25,73 mln	39,78 mln	43,73 mln	40,74 mln
Amaldagi soliq stavkasi	17,89%	19,41%	19,97%	-40,40%
Boshqa operatsion xarajatlar	-	-	-	-
Sof foyda	118,10 mln	165,16 mln	175,22 mln	-141,59 mln
Sof foyda marjasi	44,59%	50,71%	49,46%	-31,34%
Har bir aksiya foydasi	1,11	1,54	1,72	-0,24
Foizlar va investitsiyalardan olingan daromadlar	5,11 mln	-	5,33 mln	2,09 mln
Foizlarni toʻlash xarajatlari	-4,52 mln	-4,39 mln	-4,30 mln	-4,91 mln
Foizlarni toʻlash boʻyicha sof xarajatlar	584,00 ming	-4,39 mln	1,04 mln	-2,82 mln
Amortizatsiya ajratmalari	-	-	-	-
EBITDA	160,48 mln	221,44 mln	236,84 mln	279,08 mln
Aktivlarni sotishdan olingan foyda yoki zarar	-	-	-	2,62 mln

AI kontentda xatolar boʻlishi mumkin. Batafsil

YordamFikr-mulohazaMaxfiylik Shartlar Majburiyatlardan voz kechish

Finance

Tahlil